CoheaHr: Comparing Health Services interventions for the prevention of HPV-related cancer in European countries


Accueil Abstract
CoheaHr: Comparing Health Services interventions for the prevention of HPV-related cancer in European countries Tuesday, December 4, 2018 Scientific Session • SS 08 • 3:30 PM > 5:15 PM • CoheaHr: Comparing Health Services interventions for the prevention of HPV-related cancer in European countries • 5C The CoheaHr project started in 2013 and main results will be presented. The purpose of CoheaHr is to investigate the effectiveness of real-life health services in European countries. A greater emphasis on comparative effectiveness research (CER) is needed to ensure that the citizens of the European Union receive optimal, cost-effective care that they are entitled to. Prevention of HPV-associated cancers can be achieved by several strategies that may achieve different levels of effectiveness in real-life. A CER project in this area therefore meets extraordinary challenges that will undoubtedly foster excellence in CER. Presentations will be given on different primary and secondary prevention efforts in European countries, modelling studies that aim to identify optimal strategies, and meta-analyses. 3:30 PM • SS 08-01 • The rationale for the Dutch HPV-based screening programme > C. Chris MEIJER 3:42 PM • SS 08-02 • The optimal screening frequency in vaccinated women: results of a Finnish randomized controlled trial > M. Matti LEHTINEN 3:54 PM • SS 08-03 • HPV testing on self-collected versus clinician-collected samples: the IMPROVE randomized diagnostic study > H. Hans BERKHOF 4:06 PM • SS 08-04 • How to screen vaccinated women: a Swedish comparative effectiveness study > J. Jiayao LEI 4:18 PM • SS 08-05 • HPV vaccination of women in screening ages: results of a feasibility study > X. Xavier BOSCH 4:30 PM • SS 08-06 • Cancer and HGCIN risk after a negative cytology or HPV below and above age 50: a pooled analysis of EU RCTs > G. Guglielmo RONCO 4:42 PM • SS 08-07 • How to screen women beyond age 50: a model-based analysis > I. Iacopo BAUSSANO 4:54 PM • SS 08-08 • HPV-negative cervical cancers – a review > M. Marc ARBYN 5:06 PM • SS 08-09 • Discussion